Chemogenomic Landscape of RUNX1-mutated AML Reveals Importance of RUNX1 Allele Dosage in Genetics and Glucocorticoid Sensitivity.

Simon L, Lavallée VP, Bordeleau ME, Krosl J, Baccelli I, Boucher G, Lehnertz B, Chagraoui J, MacRae T, Ruel R, Chantigny Y, Lemieux S, Marinier A, Hébert J, Sauvageau G.
Chemogenomic Landscape of RUNX1-mutated AML Reveals Importance of RUNX1 Allele Dosage in Genetics and Glucocorticoid Sensitivity.
Clinical cancer research (2017), 23(22):6969-6981.

H3K27M/I mutations promote context-dependent transformation in acute myeloid leukemia with RUNX1 alterations.

Lehnertz B, Zhang YW, Boivin I, Mayotte N, Tomellini E, Chagraoui J, Lavallée VP, Hébert J, Sauvageau G.
H3K27M/I mutations promote context-dependent transformation in acute myeloid leukemia with RUNX1 alterations.
Blood (2017), 130(20):2204-2214.

EPCR expression marks UM171-expanded CD34+ cord blood stem cells. Blood.

Fares I, Chagraoui J, Lehnertz B, MacRae T, Mayotte N, Tomellini E, Aubert L, Roux PP, Sauvageau G.
EPCR expression marks UM171-expanded CD34+ cord blood stem cells. 
Blood (2017), 129(25):3344-3351.

A novel approach for the identification of efficient combination therapies in primary human acute myeloid leukemia specimens. Blood Cancer J.

Baccelli I, Krosl J, Boucher G, Boivin I, Lavallée V-P, Hébert J, Lemieux S, Marinier A, Sauvageau G.
A novel approach for the identification of efficient combination therapies in primary human acute myeloid leukemia specimens.
Blood Cancer Journal (2017), 7(2):e529.